BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18005698)

  • 1. Poxviral B1 kinase overcomes barrier to autointegration factor, a host defense against virus replication.
    Wiebe MS; Traktman P
    Cell Host Microbe; 2007 May; 1(3):187-97. PubMed ID: 18005698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrier to autointegration factor (BAF) inhibits vaccinia virus intermediate transcription in the absence of the viral B1 kinase.
    Ibrahim N; Wicklund A; Jamin A; Wiebe MS
    Virology; 2013 Sep; 444(1-2):363-73. PubMed ID: 23891157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinia Virus B1 Kinase Is Required for Postreplicative Stages of the Viral Life Cycle in a BAF-Independent Manner in U2OS Cells.
    Jamin A; Ibrahim N; Wicklund A; Weskamp K; Wiebe MS
    J Virol; 2015 Oct; 89(20):10247-59. PubMed ID: 26223647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Vaccinia Virus B12 Pseudokinase Represses Viral Replication via Interaction with the Cellular Kinase VRK1 and Activation of the Antiviral Effector BAF.
    Rico AB; Linville AC; Olson AT; Wang Z; Wiebe MS
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A poxvirus pseudokinase represses viral DNA replication via a pathway antagonized by its paralog kinase.
    Olson AT; Wang Z; Rico AB; Wiebe MS
    PLoS Pathog; 2019 Feb; 15(2):e1007608. PubMed ID: 30768651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of the host defense activity of the barrier to autointegration factor against vaccinia virus.
    Ibrahim N; Wicklund A; Wiebe MS
    J Virol; 2011 Nov; 85(22):11588-600. PubMed ID: 21880762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell- and virus-mediated regulation of the barrier-to-autointegration factor's phosphorylation state controls its DNA binding, dimerization, subcellular localization, and antipoxviral activity.
    Jamin A; Wicklund A; Wiebe MS
    J Virol; 2014 May; 88(10):5342-55. PubMed ID: 24600006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of the Vaccinia Virus B1 Kinase Reveals Essential Functions of This Enzyme Complemented Partly by the Homologous Cellular Kinase VRK2.
    Olson AT; Rico AB; Wang Z; Delhon G; Wiebe MS
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28515294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrier to auto integration factor becomes dephosphorylated during HSV-1 Infection and Can Act as a host defense by impairing viral DNA replication and gene expression.
    Jamin A; Thunuguntla P; Wicklund A; Jones C; Wiebe MS
    PLoS One; 2014; 9(6):e100511. PubMed ID: 24945635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus.
    Nichols RJ; Wiebe MS; Traktman P
    Mol Biol Cell; 2006 May; 17(5):2451-64. PubMed ID: 16495336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Vaccinia Virus (VACV) B1 and Cellular VRK2 Kinases Promote VACV Replication Factory Formation through Phosphorylation-Dependent Inhibition of VACV B12.
    Rico AB; Wang Z; Olson AT; Linville AC; Bullard BL; Weaver EA; Jones C; Wiebe MS
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAFfled by poxviruses?
    Rahman MM; McFadden G
    Cell Host Microbe; 2007 May; 1(3):159-60. PubMed ID: 18005693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus.
    Peters NE; Ferguson BJ; Mazzon M; Fahy AS; Krysztofinska E; Arribas-Bosacoma R; Pearl LH; Ren H; Smith GL
    PLoS Pathog; 2013; 9(10):e1003649. PubMed ID: 24098118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Confirmation that the H5 Protein Is Required for Vaccinia Virus DNA Replication.
    Boyle KA; Greseth MD; Traktman P
    J Virol; 2015 Jun; 89(12):6312-27. PubMed ID: 25855734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic ATR Activation Promotes Vaccinia Virus Genome Replication.
    Postigo A; Ramsden AE; Howell M; Way M
    Cell Rep; 2017 May; 19(5):1022-1032. PubMed ID: 28467896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of Cellular VRK1, BAF, and Innate Immune Signaling by the Vaccinia Virus B12 Pseudokinase.
    Linville AC; Rico AB; Teague H; Binsted LE; Smith GL; Albarnaz JD; Wiebe MS
    J Virol; 2022 Jun; 96(11):e0039822. PubMed ID: 35543552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Members of a novel family of mammalian protein kinases complement the DNA-negative phenotype of a vaccinia virus ts mutant defective in the B1 kinase.
    Boyle KA; Traktman P
    J Virol; 2004 Feb; 78(4):1992-2005. PubMed ID: 14747564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing Roles of Double-Stranded RNA Effector Pathways and Viral Defense Proteins Revealed with CRISPR-Cas9 Knockout Cell Lines and Vaccinia Virus Mutants.
    Liu R; Moss B
    J Virol; 2016 Sep; 90(17):7864-79. PubMed ID: 27334583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Host Range Restriction of the Vaccinia Virus C7/K1 Double Deletion Mutant Is Mediated by an Atypical Mode of Translation Inhibition.
    Sivan G; Glushakow-Smith SG; Katsafanas GC; Americo JL; Moss B
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference with SAMHD1 Restores Late Gene Expression of Modified Vaccinia Virus Ankara in Human Dendritic Cells and Abrogates Type I Interferon Expression.
    Sliva K; Martin J; von Rhein C; Herrmann T; Weyrich A; Toda M; Schnierle BS
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.